ATE68503T1 - Atriale peptide. - Google Patents

Atriale peptide.

Info

Publication number
ATE68503T1
ATE68503T1 AT85870029T AT85870029T ATE68503T1 AT E68503 T1 ATE68503 T1 AT E68503T1 AT 85870029 T AT85870029 T AT 85870029T AT 85870029 T AT85870029 T AT 85870029T AT E68503 T1 ATE68503 T1 AT E68503T1
Authority
AT
Austria
Prior art keywords
atrial peptides
atrial
peptides
diuretic
image
Prior art date
Application number
AT85870029T
Other languages
English (en)
Inventor
Philip Needleman
Original Assignee
Univ Washington
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Washington filed Critical Univ Washington
Application granted granted Critical
Publication of ATE68503T1 publication Critical patent/ATE68503T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/58Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Cardionatrin; Cardiodilatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Detergent Compositions (AREA)
AT85870029T 1984-05-04 1985-02-22 Atriale peptide. ATE68503T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/607,064 US4508712A (en) 1984-01-10 1984-05-04 Atrial peptide
EP85870029A EP0162032B1 (de) 1984-05-04 1985-02-22 Atriale Peptide

Publications (1)

Publication Number Publication Date
ATE68503T1 true ATE68503T1 (de) 1991-11-15

Family

ID=24430657

Family Applications (1)

Application Number Title Priority Date Filing Date
AT85870029T ATE68503T1 (de) 1984-05-04 1985-02-22 Atriale peptide.

Country Status (14)

Country Link
US (1) US4508712A (de)
EP (1) EP0162032B1 (de)
JP (1) JPH0615559B2 (de)
AT (1) ATE68503T1 (de)
AU (1) AU569776B2 (de)
CA (1) CA1244407A (de)
DE (1) DE3584388D1 (de)
DK (1) DK163930C (de)
FI (1) FI79119C (de)
GR (1) GR850474B (de)
IE (1) IE57880B1 (de)
IL (1) IL74426A (de)
NO (1) NO167295C (de)
ZA (1) ZA851376B (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1241646A (en) * 1982-02-22 1988-09-06 Adolfo J. De Bold Atrial natriuretic factor
US4761469A (en) * 1982-02-22 1988-08-02 Queen's University At Kingston Isolation, purification and sequence determination of cardionatrins
AU572173B2 (en) * 1983-08-29 1988-05-05 Institut De Recherches Cliniques De Montreal Natriuretic factors
JPS60136596A (ja) * 1983-12-26 1985-07-20 Suntory Ltd ペプチド及びこれを有効成分とする利尿剤
US4952561A (en) * 1984-02-07 1990-08-28 Merck & Co., Inc. Cardiac atrial peptides
JPH0794473B2 (ja) * 1984-03-02 1995-10-11 サントリー株式会社 新規なペプチド及びこれを有効成分とする利尿剤
US4618600A (en) * 1984-04-19 1986-10-21 Biotechnology Research Associates, J.V. Novel polypeptide diuretic/vasodilators
WO1985004872A1 (en) * 1984-04-24 1985-11-07 The Salk Institute For Biological Studies Atrial peptide analogs
NZ212291A (en) * 1984-06-08 1991-10-25 Suntory Ltd Peptide from human atrium cordis having diuretic action, dna coding therefor and pharmaceutical compositions thereof
US4670540A (en) * 1984-08-29 1987-06-02 Ajinomoto Co., Inc. Novel peptide
AU597919B2 (en) * 1985-11-05 1990-06-14 Scios Nova Inc. Analogs of atrial natriuretic peptides
US4757048A (en) * 1985-11-05 1988-07-12 Biotechnology Research Associates J.V. Synthetic analogs of atrial natriuretic peptides
US4716147A (en) * 1986-03-27 1987-12-29 Monsanto Company Synthetic airial peptides
US4721704A (en) * 1986-05-09 1988-01-26 Peninsula Laboratories, Inc. Potent synthetic atrial peptide analogs
CA1339678C (en) * 1986-09-29 1998-02-17 Takeda Chemical Industries Ltd. Atrial natriuretic peptide derivative, its production and use thereof for treating gardiac or cerebral circulatory disease
US4804650A (en) * 1986-10-28 1989-02-14 Biotechnology Research Associates, J.V. Analogs of atrial natriuretic peptides
US5500230A (en) * 1987-01-23 1996-03-19 The General Hospital Corporation Method for treatment of glaucoma with nitrogen containing guanylate cyclase activators
WO1988005306A1 (en) * 1987-01-23 1988-07-28 The General Hospital Corporation Atriopeptins, guanylate cyclase activators, and phosphodiesterase inhibitors as treatment for glaucoma, hydrocephalus and cerebral edema (cranial fluid volume dysfunction)
CA1337400C (en) * 1987-06-08 1995-10-24 Norma G. Delaney Inhibitors of neutral endopeptidase
DE3737917A1 (de) * 1987-11-07 1989-05-18 Bissendorf Peptide Gmbh Phosphorylierte derivate von cardiodilatin/anf-peptiden
US5461142A (en) * 1987-11-07 1995-10-24 Pharma Bissendorf Peptide Gmbh Phosphorylated derivatives of cardiodilatin/ANF peptides
US5047397A (en) * 1988-08-26 1991-09-10 California Biotechnology Inc. Linear analogs of atrial natriuretic peptides
CA1339210C (en) 1988-05-31 1997-08-05 John Lewicki Recombinant techniques for production of novel natriuretic and vasodilator peptides
US5114923A (en) * 1988-05-31 1992-05-19 California Biotechnology Inc. Recombinant techniques for production of novel natriuretic and vasodilator peptides
WO2007094342A1 (ja) 2006-02-14 2007-08-23 Calpis Co., Ltd. 動脈硬化予防剤、血管内膜の肥厚抑制剤及び血管内皮機能改善剤
CA2642537C (en) 2006-02-14 2013-04-09 Calpis Co., Ltd. Vasodilator
EP2678002A2 (de) 2011-02-25 2014-01-01 Medtronic, Inc. Therapie für nierenerkrankungen und/oder herzinsuffizienz
EP2750697A4 (de) 2011-09-02 2015-03-25 Medtronic Inc Chimäre natriuretische peptidzusammensetzungen und verfahren zu ihrer herstellung

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1985004872A1 (en) * 1984-04-24 1985-11-07 The Salk Institute For Biological Studies Atrial peptide analogs
NZ212291A (en) * 1984-06-08 1991-10-25 Suntory Ltd Peptide from human atrium cordis having diuretic action, dna coding therefor and pharmaceutical compositions thereof

Also Published As

Publication number Publication date
CA1244407A (en) 1988-11-08
IL74426A (en) 1989-09-10
DE3584388D1 (de) 1991-11-21
EP0162032A3 (en) 1988-03-30
US4508712A (en) 1985-04-02
JPS6127924A (ja) 1986-02-07
AU569776B2 (en) 1988-02-18
IL74426A0 (en) 1985-05-31
DK163930B (da) 1992-04-21
DK163930C (da) 1992-09-14
FI850744A0 (fi) 1985-02-22
FI79119B (fi) 1989-07-31
EP0162032A2 (de) 1985-11-21
IE57880B1 (en) 1993-05-05
EP0162032B1 (de) 1991-10-16
DK81685A (da) 1985-11-05
NO850709L (no) 1985-11-05
DK81685D0 (da) 1985-02-22
NO167295B (no) 1991-07-15
GR850474B (de) 1985-05-10
AU3907385A (en) 1985-11-07
JPH0615559B2 (ja) 1994-03-02
FI79119C (fi) 1989-11-10
NO167295C (no) 1991-10-23
IE850436L (en) 1985-11-04
ZA851376B (en) 1986-09-24
FI850744L (fi) 1985-11-05

Similar Documents

Publication Publication Date Title
ATE68503T1 (de) Atriale peptide.
ES2104635T3 (es) Nuevo peptido porcino con una actividad fisiologica (cnp-53).
DK151985D0 (da) Humant fysiologisk aktivt polypeptid
IT8619338A0 (it) Peptide sintetico ad attivita'interleukina 1 umana.
FI861007A7 (fi) Uusia peptidejä.
DE3789413D1 (de) Lymphokin-ähnliche Peptide.
DK606485D0 (da) Proteinhydrolysat
IT8522214A0 (it) Esapeptidi ad attivita' ipotensiva.
GR3024580T3 (en) Rat C-type natriuretic peptide cDNA and precursor protein
FI872959A7 (fi) Natriureettisen vaikutuksen omaavien sydämen eteispeptidien analogeja .
DE3671132D1 (de) Flache zelle.
DK139185D0 (da) Substituerede aminosyrer
IT7926703A0 (it) Peptide antibatterico a base di amminoacidi.
NO169173C (no) Veksthormon-frigjoerende peptider
AU570572B2 (en) 4,5-dihydro-4-oxo-2-((2-trans-phenylcyclopropyl) amino)-3- furancarboxylic acid derivatives
DE3481386D1 (de) Bestimmung von fibrin mit fibrin-spezifischen antikoerpern.
NZ223885A (en) Fluorine-containing atrial natriuretic peptides
NO874792L (no) Sulfat-ester peptider.
DE68914325D1 (de) Herstellung von 3,3-Diphenylacrylsäureamiden.
DE3686799D1 (en) Fuer dipterenlarven toxische polypeptide.
DE3675838D1 (de) 5-chloro-s-triazolo(4,3-a)pyridin-7-carbonsaeuren.
ATE82295T1 (de) Fluor enthaltende atriale natriuretische peptide.
Berger On critical distortion for Markov sources(Corresp.)
DE3681441D1 (de) Aminosaeureabkoemmlinge.
ATE45067T1 (de) Eiweisshydrolysat.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee